A cautionary tale from critical care: Resolution of myoclonus after fentanyl rotation to hydromorphone

Journal of Pain and Symptom Management

Volumn 40, Issue 5, 2010, Pages e4-

  Essandoh, Samuel ^a   Sakae, Mayuko ^a   Miller, Jeanna ^a   Glare, Paul A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; DIGOXIN; DILTIAZEM; DOCUSATE SODIUM; FENTANYL; FUROSEMIDE; HEPARIN; HYDROMORPHONE; IPRATROPIUM BROMIDE; LEVALBUTEROL; METOPROLOL; PIPERACILLIN PLUS TAZOBACTAM; PROPOFOL; TOBRAMYCIN;

ABDOMINAL PAIN; ADULT; ANAMNESIS; CANCER PATIENT; CANCER SURGERY; CASE REPORT; DELIRIUM; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; INTENSIVE CARE; LETTER; MALE; MYOCLONUS; POSTOPERATIVE PAIN;

EID: 78349303797     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2010.08.005     Document Type: Letter

References (16)

1. N.A. Hagen, and R. Swanson Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid administration: treatment strategies J Pain Symptom Manage 14 1997 51 58
2. R. Gallagher Opioid-induced neurotoxicity Can Fam Physician 53 2007 426 427
3. R.P. Riechelmann, C. Zimmermann, and S.N. Chin Potential drug interactions in cancer patients receiving supportive care exclusively J Pain Symptom Manage 35 2008 535 543
4. N. Latronico, I. Shehu, and E. Seghelini Neuromuscular sequelae of critical illness Curr Opin Crit Care 11 2005 381 390
5. T.R. Okon, and M.L. George Fentanyl-induced neurotoxicity and paradoxic pain J Pain Symptom Manage 35 2008 327 333
6. S. Mercadante Pathophysiology and treatment of opioid-related myoclonus in cancer patients Pain 74 1998 5 9 (Pubitemid 28097723)
7. M.T. Smith Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites Clin Exp Pharmacol Physiol 27 2000 524 528
8. A.W. Wright, L.E. Mather, and M.T. Smith Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide Life Sci 69 2001 409 420
9. H.S. Smith Opioid metabolism Mayo Clin Proc 84 2009 613 624
10. D.E. Feierman, and J.M. Lasker Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4 Drug Metab Dispos 24 1996 932 939
11. T. Tateishi, Y. Krivoruk, and Y.F. Ueng Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation Anesth Analg 82 1996 167 172
12. R. Horton, and C. Barber Opioid-induced respiratory depression resulting from transdermal fentanyl-clarithromycin drug interaction in a patient with advanced COPD J Pain Symptom Manage 37 2009 e2 e5
13. S. Mercadante, P. Villari, and P. Ferrera Itraconazole-fentanyl interaction in a cancer patient J Pain Symptom Manage 24 2002 284 286
14. S. Takeda, Y. Ishii, and P.I. Mackenzie Modulation of UDP-glucuronosyltransferase 2B7 function by cytochrome P450s in vitro: differential effects of CYP1A2, CYP2C9 and CYP3A4 Biol Pharm Bull 28 2005 2026 2027
15. S. Takeda, Y. Ishii, and M. Iwanaga Modulation of UDP- glucuronosyltransferase function by cytochrome P450: evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4 Mol Pharmacol 67 2005 665 672
16. M. Dean Opioids in renal failure and dialysis patients J Pain Symptom Manage 28 2004 497 504